1 - 10  of 31 results

Filter or search again

Sort by:  Most Relevant

  • NICE recommends ciclosporin for severe keratitis

    6 JAN 2016

    The National Institute for Health and Care Excellence (NICE) has published final guidance that recommends ciclosporin (Ikervis; Santen Pharmaceutical) for treating severe keratitis in adults with dry eye disease which has not improved despite treatment with artificial tears.

  • Oxervate gets EMA approval for rare degenerative eye disease

    24 MAY 2017

    The European Medicines Agency (EMA), which evaluates medicinal products for use in Europe, has recommended Oxervate (marketed by Dompé) for marketing authorisation for the treatment of moderate or severe neurotrophic keratitis.

  • More information required for ciclosporin

    10 JUL 2015

    The National Institute for Health and Care Excellence (NICE) has published draft guidance asking Santen Pharmaceutical for more information about ciclosporin (Ikervis) for treating severe keratitis in adults with dry eye disease that has not improved despite treatment with artificial tears. NICE has requested additional information about the cost and clinical effectiveness of the drug.

  • BNF case study: Eye problems with cancer treatment

    The Salvadore, March 2013

    A 57-year-old woman is being treated with gefitinib for metastatic non-small-cell lung cancer. During her review she mentions that her eyes have been troubling her for the past few days. She wonders if she has an infection. Both eyes appear red and inflamed, and there is some watery discharge. On further questioning, ...

  • Contaminated batches of Zovirax eye ointment recalled

    4 NOV 2014

    Contaminated batches of Zovirax (aciclovir) eye ointment are being recalled after metal particles were found in an ingredient used in its manufacture.

  • Novel plastic-derived antifungal shows promise in infections

    13 DEC 2013

    Candida albicans Source: Sebastian Kaulitzki/Dreamstime.com Candida albicans infections could be treated with the a new anti-fungal in the future...

  • Call for global action on fungal infection

    8 MAY 2015

    A project, launched by the Global Action Fund for Fungal Infections, aims to diagnose and treat 95% of patients with life- or sight-threatening fungal disease by 2025.

  • Dry eye disease: risk factors and selecting treatment

    7 OCT 2015

    Identifying the risk factors for dry eye disease and selecting the most appropriate and effective treatments.

  • Identification of dry eye conditions in community pharmacy

    9 JUN 2016

    How community pharmacists can identify patients with dry eye and how these conditions can be diagnosed.

  • Question from practice: Latanoprost as a cosmetic for eyelashes?

    The Salvadore, October 2012

    A. Latanaprost is a prostaglandin analogue available as 50µg/ml eyedrops as Xalatan and, since January 2012, in a range of generic versions. It is licensed for the reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension. Some products are also licensed for treating elevated ...

View results  10 per page   20 per page   50 per page  

Filter Your Search



сколько стоит женская виагра в аптеке